Patient insights research exploring disease awareness, patient life experience, and current management of visceral leishmaniasis in Bihar, India

Shyam Sundar,Fabiana Alves,Koert Ritmeijer,Margriet den Boer,Colin Forsyth,Bethan Hughes,Clare Zamble,Kirsten Carter,Gerhild Angyalosi
DOI: https://doi.org/10.1101/2024.07.11.24309649
2024-07-11
Abstract:Background: Visceral leishmaniasis (VL) is a vector-borne disease caused by parasites and transmitted by sand fly bites, targeted for elimination in India. VL primarily affects rural, low-income populations with limited health care access. In South Asia, few studies have explored patients perspectives, diagnoses, and treatment experiences, and how these experiences influence their expectations about treatment. Methodology/principal findings: A qualitative study was conducted in Bihar, India, using moderator-facilitated, protocol-defined discussion. Eighteen adult patients and 12 caregivers of children diagnosed with and treated for VL within the last 12 months were identified by self-report. Mean time from symptom onset to diagnosis was 13.8 days. Challenges of the patient life experience included lack of urgency by health care professionals, delayed diagnosis, and unavailability of current standard-of-care therapy where a patient receives their diagnosis (63% switched to a different center for treatment, at times delaying treatment). Key barriers include out-of-pocket financial burden, absence from work/home duties, and long-distance travel to hospitals. Patients expressed a preference (29/30) for a potential oral treatment that could be taken close to home over the current standard of care (infusions/injections in clinics). Conclusions/significance: This study reveals new insights and confirms previous research showing access to care for patients with VL in the Bihar area remains a challenge. Although most patients with VL seek care early, diagnosis often requires multiple visits to a health care facility. Despite access to therapy in public hospitals, a substantial number of patients prefer private clinics. Even in public locations, many patients need to move from the diagnostic center to another center to receive therapy, creating an additional burden for patients. As a potential alternative to current parenteral treatment, oral therapy would be preferred by adult patients and caregivers of pediatric patients and may reduce barriers to access to care.
Public and Global Health
What problem does this paper attempt to address?